The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 17, 2020

Filed:

Jul. 01, 2016
Applicant:

Koska Family Limited, East Sussex, GB;

Inventor:

Marc Andrew Koska, East Sussex, GB;

Assignee:

KOSKA FAMILY LIMITED, East Sussex, GB;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 5/24 (2006.01); A61M 5/28 (2006.01); A61M 5/50 (2006.01); A61M 5/32 (2006.01); A61M 39/24 (2006.01); A61M 5/30 (2006.01); A61M 5/46 (2006.01); A61M 5/31 (2006.01);
U.S. Cl.
CPC ...
A61M 5/2448 (2013.01); A61M 5/282 (2013.01); A61M 5/50 (2013.01); A61M 5/30 (2013.01); A61M 5/3202 (2013.01); A61M 5/3205 (2013.01); A61M 5/3216 (2013.01); A61M 5/46 (2013.01); A61M 39/24 (2013.01); A61M 2005/3114 (2013.01); A61M 2005/3128 (2013.01);
Abstract

The invention is a single use delivery device configured to enable reconstitution of a lyophilized agent (e.g., vaccine, drug, medicament, etc.) stored within for subsequent delivery of the reconstituted fluid agent to a patient in a controlled manner and without requiring specialized skill in reconstituting the agent or administering delivery of such agent. The delivery device is prefilled with an individual dose of a lyophilized agent and configured to be filled on-site and in the field with a dose of diluent for reconstitution of the lyophilized agent, while remaining sterile and preventing the potential for contamination during the filling process. The delivery device is further configured to be rendered incapable of reuse followings its intended use of delivering the fluid agent to a patient, thereby preventing reuse of the device and reducing the risk of the spreading blood-borne diseases through reuse.


Find Patent Forward Citations

Loading…